Larvol Delta - VERANDASSc-Design-of-a-Phase-III-Doubleblind-Randomized-Placebocontrolled-Trial-Evaluating-the-Safety-and-Efficacy-of-Oral-Nerandomilast-Treatment-on-Halting-Disease-Progression-in-Systemic-Sclerosis

Jascayd (nerandomilast) - Boehringer Ingelheim

https://acrconvergence2026.eventscribe.net/fsPopup.asp?PresentationID=1896599&mode=presInfo

Elizabeth Volkmann, MD, MS

Sep 8, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next